SUBSCRIBE
SUBSCRIBE
News   Business

Incyte Corporation Arthritis Drug Shows Promise; Positive Phase 2 Data Triggers $30 Million Milestone from Eli Lilly and Company

May 6, 2010 | 
1 min read

Reuters -- Biotechnology firm Incyte Corp said data from a mid-stage trial of its experimental rheumatoid arthritis treatment showed the drug was safe and effective.

Alliances Clinical research Phase II
Eli Lilly and Company Incyte
MORE ON THIS TOPIC
Note paper with blood donation concept on red background
Sickle cell disease
Vertex, Beam Report SCD Cell and Gene Therapies Advances at ASH 2024
December 9, 2024
 · 
2 min read
 · 
Tristan Manalac
Businessman holding a dart aiming at the target - business targeting, aiming, focus concept. Art collage.
Bladder cancer
Protara, CG Oncology Tout Promising Bladder Cancer Outcomes
December 6, 2024
 · 
2 min read
 · 
Tristan Manalac
Pictured: Eli Lilly's biotechnology center in California
Manufacturing
Lilly Pumps $3B Into Wisconsin Site as Compounders Close In on Tirzepatide
December 6, 2024
 · 
2 min read
 · 
Tristan Manalac
Amgen sign at its headquarters in Thousand Oaks, California, USA.
Manufacturing
Amgen to Add 370 New Jobs in North Carolina With $1B Manufacturing Investment
December 6, 2024
 · 
2 min read
 · 
Tristan Manalac